SCHEMBL533539

SCHEMBL533539

Cc1cc(C)c(N2CCCC2)c(C)c1NC(=O)c1cccc(Br)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.47
▸ GAA P10253 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ NPC1 O15118 2/20 0.46
▸ ATM Q13315 1/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ LMNA P02545 1/20 0.46
▸ CHRNA1 P02708 1/20 0.45
▸ CHRNG P07510 1/20 0.45
▸ CHRNB1 P11230 1/20 0.45
▸ CHRNB2 P17787 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ CHRNB4 P30926 1/20 0.45
▸ CHRNA3 P32297 1/20 0.45
▸ CHRNA4 P43681 1/20 0.45
▸ SLC6A3 Q01959 1/20 0.45
▸ CHRND Q07001 1/20 0.45
▸ GRM5 P41594 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ NLRP3 Q96P20 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL533054 0.88 MAPT (0.45) RAB9ANPC1SMN1; SMN2LMNAMEN1
SCHEMBL532941 0.88 MAPT (0.51) RAB9ANPC1SMN1; SMN2CHRNA1CHRNG
SCHEMBL532849 0.87 SMN1; SMN2 (0.49) RAB9AGAAHTTNPC1SMN1; SMN2
SCHEMBL532034 0.86 NPC1 (0.57) RAB9AGAAHTTNPC1LMNA
SCHEMBL534191 0.86 ALDH1A1 (0.50) RAB9AGAANPC1SMN1; SMN2LMNA
SCHEMBL534049 0.85 SCN9A (0.47) RAB9AHTTNPC1SMN1; SMN2GRM5
SCHEMBL532995 0.82 NPC1 (0.54) RAB9AGAANPC1SMN1; SMN2LMNA
SCHEMBL533434 0.81 ALDH1A1 (0.44) RAB9AGAANPC1ATMSMN1; SMN2
SCHEMBL532967 0.81 RAB9A (0.57) RAB9AGAANPC1SMN1; SMN2LMNA
SCHEMBL532794 0.81 POLB (0.45) RAB9AGAAHTTNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 — — EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 — — US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 — — US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 — — US disclosed
Send feedback